Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells.
about
Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells.Na+/H+ exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells.RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.Contributions of 3D Cell Cultures for Cancer Research.GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance.
P2860
Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibition of RSK with the nov ...... eliminating cancer stem cells.
@ast
Inhibition of RSK with the nov ...... eliminating cancer stem cells.
@en
type
label
Inhibition of RSK with the nov ...... eliminating cancer stem cells.
@ast
Inhibition of RSK with the nov ...... eliminating cancer stem cells.
@en
prefLabel
Inhibition of RSK with the nov ...... eliminating cancer stem cells.
@ast
Inhibition of RSK with the nov ...... eliminating cancer stem cells.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of RSK with the nov ...... eliminating cancer stem cells.
@en
P2093
Alastair H Davies
Anna L Stratford
Kristen Reipas
Natalie Firmino
Rachel Berns
Sandra E Dunn
P2860
P304
20570-20577
P356
10.18632/ONCOTARGET.4135
P407
P577
2015-05-14T00:00:00Z